NNZ-2591 ( DrugBank: NNZ-2591 )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
201	アンジェルマン症候群	1

201. アンジェルマン症候群

臨床試験数 : 24 / 薬物数 : 35 - (DrugBank : 9) / 標的遺伝子数 : 22 - 標的パスウェイ数 : 20

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05011851 (ClinicalTrials.gov)	October 1, 2021	5/8/2021	An Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Oral NNZ-2591in Angelman Sy ...	An Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Oral NNZ-2591in Angelman Sy ...	Angelman Syndrome	Drug: NNZ-2591	Neuren Pharmaceuticals Limited	NULL	Not yet recruiting	3 Years	17 Years	All	20	Phase 2	Australia

First Previous1Next Last